论文部分内容阅读
Objective The aim was to assess the association between fasting plasma glucose (FPG) levels on admission and mortality in older patients with acute myocardial infarction (AMI), and compare the effects of FPG levels on outcomes in the context of contemporary treatments, including medical therapy, percutaneous coronary intervention and coronary artery bypass grafting.